pentetic acid has been researched along with Cancer of Prostate in 37 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neuroendocrine differentiation of prostate cancer (PCa) is a relatively frequent event, generally understudied, that carries important prognostic information." | 2.55 | Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer. ( Ciarmiello, A; Giovacchini, G; Giovannini, E; Riondato, M, 2017) |
| "However, after pre-targeting of human prostate cancer PC3 cells with Bom-BiSpCx and targeting with D-Dox-PGA, IC50 (13." | 1.39 | In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates. ( Gada, K; Khaw, BA; Majewski, S; Panwar, R; Patil, V; Tekabe, Y; Varvarigou, A, 2013) |
| "Pretargeting prostate cancer with Bom-bsCx or Bom-bsFCx enabled fast delivery of high specific radioactivity ¹¹¹In- or ⁹⁹mTc-labeled polymer-drug conjugates resulting in visualization of lesions smaller than 1- 2 mm in diameter within 3 h." | 1.38 | Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates. ( Ferris, C; Gada, K; Khaw, BA; Majewski, S; Panwar, R; Patil, V; Tekabe, Y; Varvarigou, A; Weisenberger, A, 2012) |
| "In 57 patients with prostate cancer, MR imaging was performed with the following sequences: T1-weighted SE, T2-weighted fast SE, single-section gadolinium-enhanced dynamic subtracted TurboFLASH (one image every 1." | 1.30 | Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. ( Barentsz, JO; de la Rosette, JJ; Jager, GJ; Oosterhof, GO; Ruijs, SH; Ruijter, ET; Thornbury, JR; van de Kaa, CA, 1997) |
| "No advantages in detecting prostate cancer, in differentiating cancer from BPH or normal prostatic tissue, or in assessing extra-prostatic spread of cancer were observed for the contrast-enhanced studies compared to T2-weighted FSE imaging." | 1.29 | Gadolinium-enhanced MRI of the abnormal prostate. ( Herfkens, R; McNeal, J; Nghiem, HV; Sommer, FG, 1993) |
| "In Gd-DTPA enhanced images of bladder cancer, the muscle layer became more distinct, and the images of tumor and bladder mucosa were enhanced, suggesting that facilitates evaluation of the extent of bladder wall invasion of the tumor." | 1.27 | [Clinical application of MRI for urological malignancy. 3: A new trial of MRI for bladder cancer and prostatic cancer; surface coil and GD-DTPA]. ( Hida, S; Nakano, Y; Nishimura, K; Nishio, Y; Yoshida, O, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.51) | 18.7374 |
| 1990's | 14 (37.84) | 18.2507 |
| 2000's | 7 (18.92) | 29.6817 |
| 2010's | 9 (24.32) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Shetewi, SG | 1 |
| Alyami, J | 1 |
| Al Mutairi, BS | 1 |
| Bafaraj, SM | 1 |
| Tsai, WK | 1 |
| Zettlitz, KA | 1 |
| Dahlbom, M | 1 |
| Reiter, RE | 1 |
| Wu, AM | 1 |
| Patil, V | 2 |
| Gada, K | 2 |
| Panwar, R | 2 |
| Majewski, S | 2 |
| Tekabe, Y | 2 |
| Varvarigou, A | 2 |
| Khaw, BA | 2 |
| Fowler, RA | 1 |
| Fossheim, SL | 1 |
| Mestas, JL | 1 |
| Ngo, J | 1 |
| Canet-Soulas, E | 1 |
| Lafon, C | 1 |
| Pujatti, PB | 1 |
| Foster, JM | 1 |
| Finucane, C | 1 |
| Hudson, CD | 1 |
| Burnet, JC | 1 |
| Pasqualoto, KFM | 1 |
| Mengatti, J | 1 |
| Mather, SJ | 1 |
| de Araújo, EB | 1 |
| Sosabowski, JK | 1 |
| Vilhelmsson-Timmermand, O | 1 |
| Santos, E | 1 |
| Thorek, DL | 1 |
| Evans-Axelsson, S | 1 |
| Bjartell, A | 1 |
| Lilja, H | 1 |
| Larson, SM | 1 |
| Strand, SE | 1 |
| Tran, TA | 1 |
| Ulmert, D | 1 |
| Butterworth, KT | 1 |
| Nicol, JR | 1 |
| Ghita, M | 1 |
| Rosa, S | 1 |
| Chaudhary, P | 1 |
| McGarry, CK | 1 |
| McCarthy, HO | 1 |
| Jimenez-Sanchez, G | 1 |
| Bazzi, R | 1 |
| Roux, S | 1 |
| Tillement, O | 1 |
| Coulter, JA | 1 |
| Prise, KM | 1 |
| Giovacchini, G | 1 |
| Giovannini, E | 1 |
| Riondato, M | 1 |
| Ciarmiello, A | 1 |
| Kelly, MP | 1 |
| Lee, ST | 1 |
| Lee, FT | 1 |
| Smyth, FE | 1 |
| Davis, ID | 1 |
| Brechbiel, MW | 1 |
| Scott, AM | 1 |
| Kiss, P | 1 |
| Eltoum, IE | 1 |
| Suranyi, P | 1 |
| Zeng, H | 1 |
| Simor, T | 1 |
| Elgavish, A | 1 |
| Elgavish, GA | 1 |
| Schneider, DW | 1 |
| Heitner, T | 1 |
| Alicke, B | 2 |
| Light, DR | 1 |
| McLean, K | 1 |
| Satozawa, N | 1 |
| Parry, G | 2 |
| Yoo, J | 1 |
| Lewis, JS | 2 |
| Parry, R | 2 |
| Ho, CL | 1 |
| Chen, LC | 1 |
| Lee, WC | 1 |
| Chiu, SP | 1 |
| Hsu, WC | 1 |
| Wu, YH | 1 |
| Yeh, CH | 1 |
| Stabin, MG | 1 |
| Jan, ML | 1 |
| Lin, WJ | 1 |
| Lee, TW | 1 |
| Chang, CH | 1 |
| Weisenberger, A | 1 |
| Ferris, C | 1 |
| Accardo, A | 1 |
| Salsano, G | 1 |
| Morisco, A | 1 |
| Aurilio, M | 1 |
| Parisi, A | 1 |
| Maione, F | 1 |
| Cicala, C | 1 |
| Tesauro, D | 1 |
| Aloj, L | 1 |
| De Rosa, G | 1 |
| Morelli, G | 1 |
| Nedrow-Byers, JR | 1 |
| Jabbes, M | 1 |
| Jewett, C | 1 |
| Ganguly, T | 1 |
| He, H | 1 |
| Liu, T | 1 |
| Benny, P | 1 |
| Bryan, JN | 1 |
| Berkman, CE | 1 |
| Schneider, D | 1 |
| Hudson, D | 1 |
| Parkes, D | 1 |
| Xuan, JA | 1 |
| Newton, A | 1 |
| Toy, P | 1 |
| Lin, R | 1 |
| Harkins, R | 1 |
| Biroc, S | 1 |
| Kretschmer, PJ | 1 |
| Halks-Miller, M | 1 |
| Klocker, H | 1 |
| Zhu, Y | 1 |
| Larsen, B | 1 |
| Cobb, RR | 1 |
| Bringmann, P | 1 |
| Roth, G | 1 |
| Dinter, H | 1 |
| Salem, CE | 1 |
| Hoh, CK | 1 |
| Wallace, AM | 1 |
| Vera, DR | 1 |
| Abbas Rizvi, SM | 1 |
| Li, Y | 1 |
| Song, EY | 1 |
| Qu, CF | 1 |
| Raja, C | 1 |
| Morgenstern, A | 1 |
| Apostolidis, C | 1 |
| Allen, BJ | 1 |
| Hör, G | 1 |
| Heidenreich, P | 1 |
| Pabst, HW | 1 |
| Nilsson, S | 1 |
| Reubi, JC | 1 |
| Kalkner, KM | 1 |
| Laissue, JA | 1 |
| Horisberger, U | 1 |
| Olerud, C | 1 |
| Westlin, JE | 1 |
| Chanson, P | 1 |
| Schaison, G | 1 |
| Yoshizako, T | 1 |
| Sugimura, K | 1 |
| Kaji, Y | 1 |
| Moriyama, M | 1 |
| Wada, A | 1 |
| Sommer, FG | 1 |
| Nghiem, HV | 1 |
| Herfkens, R | 1 |
| McNeal, J | 1 |
| Tempany, CM | 1 |
| Masoudi, FA | 1 |
| Marshall, FF | 1 |
| Venz, S | 1 |
| Hosten, N | 1 |
| Friedrichs, R | 1 |
| Neumann, K | 1 |
| Cordes, M | 1 |
| Nagel, R | 1 |
| Felix, R | 1 |
| Quinn, SF | 1 |
| Franzini, DA | 1 |
| Demlow, TA | 1 |
| Rosencrantz, DR | 1 |
| Kim, J | 1 |
| Hanna, RM | 1 |
| Szumowski, J | 1 |
| Mirowitz, SA | 1 |
| Brown, JJ | 1 |
| Heiken, JP | 1 |
| Suzuki, T | 1 |
| Nakano, K | 1 |
| Tomiyoshi, K | 1 |
| Sakata, I | 1 |
| Endo, K | 1 |
| Yamanaka, H | 1 |
| Hayashi, N | 1 |
| Kawamura, J | 1 |
| Sugimura, Y | 1 |
| Jager, GJ | 1 |
| Ruijter, ET | 1 |
| van de Kaa, CA | 1 |
| de la Rosette, JJ | 1 |
| Oosterhof, GO | 1 |
| Thornbury, JR | 1 |
| Ruijs, SH | 1 |
| Barentsz, JO | 1 |
| Swailem, FM | 1 |
| Krishnamurthy, GT | 1 |
| Srivastava, SC | 1 |
| Aguirre, ML | 1 |
| Ellerson, DL | 1 |
| Walsh, TK | 1 |
| Simpson, L | 1 |
| Shah, J | 1 |
| Capito, PR | 1 |
| Wang, H | 1 |
| Brem, H | 1 |
| Ahn, HS | 1 |
| Bryan, RN | 1 |
| Perälä, M | 1 |
| Vihko, P | 2 |
| Södervall, M | 1 |
| Heikkilä, J | 2 |
| Vihko, R | 2 |
| Chu, TM | 1 |
| Shih, WJ | 1 |
| Wierzbinski, B | 1 |
| Magoun, S | 1 |
| Ryo, UY | 1 |
| Nishimura, K | 1 |
| Hida, S | 1 |
| Nishio, Y | 1 |
| Yoshida, O | 1 |
| Nakano, Y | 1 |
| Kontturi, M | 1 |
| Lukkarinen, O | 1 |
| Martikainen, P | 1 |
| Pelliniemi, L | 1 |
3 reviews available for pentetic acid and Cancer of Prostate
| Article | Year |
|---|---|
Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
Topics: Bombesin; Gallium Radioisotopes; Gastrin-Releasing Peptide; Germanium; Heterocyclic Compounds, 1-Rin | 2017 |
Magnetic resonance imaging diagnosis of an intracranial metastasis of adenocarcinoma of the prostate: case report.
Topics: Adenocarcinoma; Brain Neoplasms; Craniotomy; Diagnosis, Differential; Gadolinium DTPA; Humans; Magne | 1991 |
Potential applications of monoclonal antibodies in cancer diagnosis and therapy.
Topics: Adenocarcinoma; alpha-Fetoproteins; Animals; Antibodies, Monoclonal; Antibody Specificity; Antigens, | 1985 |
1 trial available for pentetic acid and Cancer of Prostate
| Article | Year |
|---|---|
The use of dynamic magnetic resonance imaging to evaluate orthotopic continent urinary diversion.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Case-Control Studies; Contrast Media; Cystectomy; Gadolin | 1995 |
33 other studies available for pentetic acid and Cancer of Prostate
| Article | Year |
|---|---|
Sensitivity and specificity of nuclear medicines (DTPA and DMSA) with magnetic resonance imaging in diagnosing bone metastasis.
Topics: Bone Neoplasms; Carcinoma; Humans; Magnetic Resonance Imaging; Male; Nuclear Medicine; Pentetic Acid | 2022 |
Evaluation of [
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Line, Tumor; Cell Proliferation; Dose-Resp | 2020 |
In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Bispecific; Bombesin; Cell Line; Cell Line, Tumor; | 2013 |
Non-invasive magnetic resonance imaging follow-up of sono-sensitive liposome tumor delivery and controlled release after high-intensity focused ultrasound.
Topics: Animals; Cell Line, Tumor; Contrast Media; Delayed-Action Preparations; Follow-Up Studies; Gadoliniu | 2013 |
Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models.
Topics: Animals; Bombesin; Breast Neoplasms; Cell Line, Tumor; Drug Stability; Female; Heterocyclic Compound | 2015 |
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Humans; Immunocompetence; Immunoconjugat | 2015 |
Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy.
Topics: Animals; Cell Line, Tumor; Cone-Beam Computed Tomography; Gold; Humans; Male; Metal Nanoparticles; M | 2016 |
Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis | 2009 |
Virtual in vivo biopsy map of early prostate neoplasm in TRAMP mice by MRI.
Topics: Adenocarcinoma; Animals; Biopsy; Contrast Media; Diagnosis, Differential; Disease Models, Animal; Di | 2009 |
In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Chelating Agents; Humans; Indium Radioisotopes; I | 2009 |
Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice.
Topics: Animals; Binding, Competitive; Bombesin; Cell Line, Tumor; Disease Models, Animal; Drug Stability; F | 2009 |
Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Antineoplastic Agents; Bombesin; Cell Line, | 2012 |
Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.
Topics: Animals; Antineoplastic Agents; Bombesin; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Deliver | 2012 |
A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent.
Topics: Adenocarcinoma; Amides; Animals; Cell Line, Tumor; Humans; In Vitro Techniques; Male; Mice; Mice, Nu | 2012 |
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibody Specificity; Bone Neoplasms; CHO Cell | 2005 |
A preclinical study of prostate sentinel lymph node mapping with [99mTC]diethylenetetramine pentaacetic acid-mannosyl-dextran.
Topics: Animals; Dextrans; Male; Mannans; Organotechnetium Compounds; Pentetic Acid; Prostatic Neoplasms; Se | 2006 |
Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model.
Topics: Animals; Bismuth; Chelating Agents; Cycloheximide; Humans; Male; Mice; Mice, Nude; Neoplasm Metastas | 2006 |
[Changing emphasis in nuclear medical diagnosis of kidney diseases].
Topics: Adult; Bone Neoplasms; Child; Humans; Hydronephrosis; Iodine Radioisotopes; Iodohippuric Acid; Kidne | 1980 |
Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Animals; Bone Neoplasms; Humans; Indium Radioisotopes; Male | 1995 |
Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma.
Topics: Adenoma; Aged; Contrast Media; Cyproterone Acetate; Gadolinium; Gadolinium DTPA; Humans; Magnetic Re | 1995 |
[Prostate and prostatic carcinoma: comparison of gadolinium-enhanced MR images and histopathologic findings].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Res | 1995 |
Gadolinium-enhanced MRI of the abnormal prostate.
Topics: Aged; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organo | 1993 |
[Osteoplastic bone metastases in prostatic carcinoma: magnetic resonance tomography and bone marrow scintigraphy].
Topics: Aged; Antibodies, Monoclonal; Bone Marrow; Carcinoma; Contrast Media; Diphosphonates; Evaluation Stu | 1994 |
MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens.
Topics: Aged; Contrast Media; Drug Combinations; False Negative Reactions; False Positive Reactions; Gadolin | 1994 |
Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging.
Topics: Aged; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; | 1993 |
Contrast enhancement of PC-3 prostate cancer for magnetic resonance imaging: animal studies using tumor-localizing Mn-metalloporphyrin (THF-Mn-Asp).
Topics: Animals; Aspartic Acid; Contrast Media; Deuteroporphyrins; Gadolinium DTPA; Humans; Image Enhancemen | 1996 |
[Endorectal magnetic resonance imaging for staging of prostatic cancer].
Topics: Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; | 1996 |
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
Topics: Aged; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Mag | 1997 |
In-vivo tissue uptake and retention of Sn-117m(4+)DTPA in a human subject with metastatic bone pain and in normal mice.
Topics: Adenocarcinoma; Animals; Bone Neoplasms; Humans; Kidney; Liver; Male; Mice; Mice, Inbred BALB C; Mid | 1998 |
Biodistribution in normal mice of an 111In-labelled prostatic acid phosphatase-specific antibody and its F(ab')2 fragments derivatized site-specifically or via bicyclic diethylenetriaminepentaacetic acid anhydride.
Topics: Acid Phosphatase; Animals; Antibodies, Monoclonal; Immunoglobulin Fab Fragments; Indium Radioisotope | 1990 |
Technetium-99m DTPA localized in gynecomastia secondary to orchiectomy and estrogen therapy in a patient with carcinoma of the prostate.
Topics: Aged; Combined Modality Therapy; Estrogens, Conjugated (USP); Gynecomastia; Humans; Male; Orchiectom | 1988 |
[Clinical application of MRI for urological malignancy. 3: A new trial of MRI for bladder cancer and prostatic cancer; surface coil and GD-DTPA].
Topics: Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Or | 1988 |
Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinoma.
Topics: Acid Phosphatase; Antibodies, Monoclonal; Humans; Immunoglobulin Fab Fragments; Indium Radioisotopes | 1987 |